The neuropeptide catestatin promotes vascular smooth muscle cell proliferation through the Ca2+–calcineurin–NFAT signaling pathway
► Catestatin stimulates proliferation of vascular smooth muscle cells in a dose-dependent manner. ► Catestatin provokes sustained increase in intracellular Ca2+. ► Catestatin produces increased activation of calcineurin and promotes NFATc1 translocation into the nucleus. The Chromogranin A-derived n...
Saved in:
Published in | Biochemical and biophysical research communications Vol. 407; no. 4; pp. 807 - 812 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
22.04.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | ► Catestatin stimulates proliferation of vascular smooth muscle cells in a dose-dependent manner. ► Catestatin provokes sustained increase in intracellular Ca2+. ► Catestatin produces increased activation of calcineurin and promotes NFATc1 translocation into the nucleus.
The Chromogranin A-derived neuropeptide catestatin is an endogenous nicotinic cholinergic antagonist that acts as a pleiotropic hormone. Since catestatin shares several functions with other members derived from the chromogranin/secretogranin protein family and other neuropeptides which exert proliferative effects on vascular smooth muscle cells (VSMCs), we therefore hypothesized that catestatin would regulate VSMC proliferation. The present study demonstrates that catestatin caused a dose-dependent induction of proliferation in rat aortic smooth muscle cells and furthermore evoked a sustained increase in intracellular calcium. This subsequently leaded to enhanced activation of the Ca2+/calmodulin-dependent phosphatase, calcineurin and resulted in an activation of the Ca2+-dependent transcription factor, nuclear factor of activated T cells (NFAT), initiating transcription of proliferative genes. In addition, cyclosporin A (CsA), a potent inhibitor of calcineurin, abrogated catestatin-mediated effect on VSMCs, indicating that the calcineurin–NFAT signaling is strongly required for catestatin-induced growth of VSMCs. The present study establishes catestatin as a novel proliferative cytokine on vascular smooth muscle cells and this effect is mediated by the Ca2+–calcineurin–NFAT signaling pathway. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0006-291X 1090-2104 |
DOI: | 10.1016/j.bbrc.2011.03.104 |